SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 375,130.88 |
Enterprise Value ($M) | 390,657.88 |
Book Value ($M) | 71,490.00 |
Book Value / Share | 29.71 |
Price / Book | 5.25 |
NCAV ($M) | -44,011.00 |
NCAV / Share | -18.29 |
Price / NCAV | -8.52 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.17 |
Return on Assets (ROA) | 0.13 |
Return on Equity (ROE) | 0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.03 |
Current Ratio | 1.26 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 71,551.00 |
Assets | 193,671.00 |
Liabilities | 115,562.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 88,821.00 |
Operating Income | 21,249.00 |
Net Income | 14,066.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 24,266.00 |
Cash from Investing | -18,599.00 |
Cash from Financing | -3,132.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
887,061 | 5,461,529 | 16.24 | |
882,148 | 3,838,319 | 22.98 | |
1,267,062 | 4,275,834 | 29.63 | |
(click for more detail) |
Similar Companies | |
---|---|
EBS – Emergent BioSolutions Inc. | ELAN – Elanco Animal Health Incorporated |
HYAC – Haymaker Acquisition Corp. 4 | LLY – Eli Lilly and Company |
MRK – Merck & Co., Inc. |